Click here to go to the previous page
China: Chain to Global Multi-Center Clinical Trial
Program Code:
3055
Date:
Wednesday, May 20, 2009
Time:
2:00 PM to 3:30 PM
EST
SPEAKER
(S):
Samantha Du, PhD, Chief Executive Officer, Hutchison Medipharma
William Keller, Former General Manager, Roche (China)
Lanzhong Wang, General Manager, Shanghai Zhangjiang Biotech & Pharmaceutical Base Developmen
Xiaolin Wei, PhD, Vice President, Shanghai Zhangjiang Biotech & Pharmaceutical Base Developmen
James Zhu, PhD, Esq, MBA, Perkins Coie, LLP
Description
China leads with the fastest growth rates in the global economy. As the environment for drug development and registration has matured, State Food and Drug Administration (equivalent to US FDA) pays more attention in drug and biotechnology development. This panel will give comprehensive information about China GLP & GCP regulatory and competition service.
• Introduce the regulatory of GLP & GCP in China
• Share the experience of how to develop MCTs in China
• Present the development of MCTs in China